Despite some progress, too many people are still dying of advanced breast cancer (ABC) too early each year. The burden of the disease is expected to increase dramatically in the coming years with the developing world hit hardest. With the advances in science, technology and communication tools, it is imperative that the cancer community around the globe joins forces to raise awareness of the disease and lobby for better outcomes for people living with ABC.
The ABC Global Alliance, established by the European School of Oncology, is a multi-stakeholder platform for all those interested in collaborating on common projects relating to ABC. Launched at the World Cancer Congress in 2016, its goal is to improve and extend the lives of women and men living with ABC in all countries worldwide and to fight for a cure.
The ABC Global Alliance invites all interested participants who are registered to attend the ABC4 Conference to join its first meeting which starts immediately after the ABC4 Conference and will be held Auditorium VI across two half day sessions at the following times:
- Part 1: Saturday, 4 November, from 15:00 to 17:30, and
- Part 2: Sunday, 5 November, from 8:30 to 13:00
On behalf of everyone at the ABC Global Alliance, we look forward to welcoming you in Lisbon.
The ABC Global Alliance is an ESO initiative sponsored through unrestricted grants provided by AstraZeneca (Main Sponsor), Novartis (Main Sponsor), Pfizer (Main Sponsor) and Lilly (Sponsor).